Eurogentec S.A., part of Kaneka Corporation, is a leading global supplier of innovative reagents, kits, specialty products and custom services. Through its three inter-related business units (BU), the company provides high quality products to scientists involved in the life science, biotechnology, diagnostic and pharmaceutical markets. Eurogentec is fully ISO 9001, ISO 13485 certified, cGMP accredited by the Belgian Ministry of Health and approved by the US FDA for the commercial manufacturing of a biologic for the US market.
The Life Science Research BU is specialized in innovative solutions in Genomics and Proteomics. Eurogentec proposes a wide range of reagents, kits and consumables for Life Science applications such as Custom Oligonucleotides, high performance PCR/qPCR Kits & Reagents, catalogue dyes, peptides & antibodies. Eurogentec is also specialist in the design and synthesis of custom peptides and production of custom antibodies.
The Diagnostic Services BU provides technical and project support for contract manufacturing of GMP oligonucleotides and Taq DNA polymerases for use in Molecular Diagnostic applications. Eurogentec also proposes the production of custom pre-dispensed assays and OEM partnership.
As a certified ISO 13485 and GMP compliant manufacturer, our manufacturing processes take place in classified clean rooms with controlled processes and full traceability. Our production facilities in Belgium enable high quality materials for the in vitro Diagnostic community.
The GMP BioManufacturing BU is a US FDA inspected full-service Contract Manufacturing Organization (CMO). It offers expertise in technology transfer, process development, scale-up and cGMP manufacturing of proteins, protein conjugates, plasmid DNA and bacterial vaccines for pre-clinical, clinical and commercial uses. Experts in microbial production (E. coli, P. pastoris, etc), Eurogentec offers various development strategies based on protein refolding, periplasmic expression, and protein expression by secretion. As a one-stop shop, Eurogentec provides a complete gene to injectable service offering. Eurogentec has been GMP since 1994 and has developed over 100 different GMP biopharmaceuticals.
History & Network
Eurogentec was founded in 1985 as a spin-off from the University of Liège (Belgium) and its headquarters are located in the LIEGE Science Park. The company has subsidiaries in France, Germany, UK, the Netherlands and Switzerland and production facilities in Liège (BE), Camberly (UK)and Fremont (USA).
In 2009, Eurogentec acquired AnaSpec, a privately held proteomics company based in Fremont, California. Founded in 1993, AnaSpec is a leading provider of integrated proteomics solutions for life science research and diagnostics with expertise in peptides synthesis, labeled peptides and antibodies, fluorescent dyes and enzyme activity assays.
The EGT Group currently employs around 325 people, including more than 40 PhDs.
In 2010, Eurogentec became part of Kaneka Corporation, Osaka, Japan. Kaneka is an innovation-oriented chemical company. Traditionally the company has been active in polymers, fermentation, biotechnology and electronics, as well as other fields. Business activities now span a broad spectrum of markets ranging from plastics, EPS resins, chemicals and foodstuffs to pharmaceutical intermediates, medical devices, electrical and electronic materials and synthetic fibers. The life science related activities are currently one of the strategically important domains for Kaneka. The company has been a pioneer among Japanese chemical companies in establishing overseas operations, beginning in 1970 with a subsidiary in Belgium. Kaneka Corporation is a company headquartered in Osaka, Japan, with subsidiaries in Belgium, the United States, Singapore, Malaysia, China, Australia, Vietnam, India, South Korea and Taiwan. Kaneka employs more than 8400 people worldwide.